【表紙】

 

【提出書類】

有価証券報告書

【根拠条文】

金融商品取引法第24条第１項

【提出先】

関東財務局長

【提出日】

平成29年３月31日

【事業年度】

第13期（自　平成28年１月１日　至　平成28年12月31日）

【会社名】

オンコリスバイオファーマ株式会社

【英訳名】

Oncolys BioPharma Inc.

【代表者の役職氏名】

代表取締役社長　　浦田　泰生

【本店の所在の場所】

東京都港区虎ノ門四丁目１番28号

【電話番号】

03-5472-1578（代表）

【事務連絡者氏名】

取締役経営管理担当　　紙谷　賢志

【最寄りの連絡場所】

東京都港区虎ノ門四丁目１番28号

【電話番号】

03-5472-1578（代表）

【事務連絡者氏名】

取締役経営管理担当　　紙谷　賢志

【縦覧に供する場所】

株式会社東京証券取引所

（東京都中央区日本橋兜町２番１号）

 

E30058 45880 オンコリスバイオファーマ株式会社 Oncolys BioPharma Inc. 企業内容等の開示に関する内閣府令 第三号様式 Japan GAAP false CTE 2016-01-01 2016-12-31 FY 2016-12-31 2015-01-01 2015-12-31 2015-12-31 1 false false false E30058-000 2015-01-01 2015-12-31 jppfs_cor:NonConsolidatedMember E30058-000 2014-12-31 jppfs_cor:NonConsolidatedMember E30058-000 2014-01-01 2014-12-31 jppfs_cor:NonConsolidatedMember E30058-000 2013-12-31 jppfs_cor:NonConsolidatedMember E30058-000 2013-01-01 2013-12-31 jppfs_cor:NonConsolidatedMember E30058-000 2012-12-31 jppfs_cor:NonConsolidatedMember E30058-000 2012-01-01 2012-12-31 jppfs_cor:NonConsolidatedMember E30058-000 2014-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:ValuationAndTranslationAdjustmentsMember E30058-000 2014-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:CapitalStockMember E30058-000 2014-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:LegalCapitalSurplusMember E30058-000 2014-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:CapitalSurplusMember E30058-000 2014-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:RetainedEarningsBroughtForwardMember E30058-000 2014-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:RetainedEarningsMember E30058-000 2014-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:ShareholdersEquityMember E30058-000 2014-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember E30058-000 2015-01-01 2015-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:RetainedEarningsBroughtForwardMember E30058-000 2015-01-01 2015-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:ShareholdersEquityMember E30058-000 2015-01-01 2015-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:CapitalStockMember E30058-000 2015-01-01 2015-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:LegalCapitalSurplusMember E30058-000 2015-01-01 2015-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:CapitalSurplusMember E30058-000 2015-01-01 2015-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:RetainedEarningsMember E30058-000 2015-01-01 2015-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember E30058-000 2015-01-01 2015-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:ValuationAndTranslationAdjustmentsMember E30058-000 2015-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:ValuationAndTranslationAdjustmentsMember E30058-000 2015-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:CapitalStockMember E30058-000 2015-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:LegalCapitalSurplusMember E30058-000 2015-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:CapitalSurplusMember E30058-000 2015-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:RetainedEarningsBroughtForwardMember E30058-000 2015-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:RetainedEarningsMember E30058-000 2015-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:ShareholdersEquityMember E30058-000 2015-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember E30058-000 2016-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:ShareholdersEquityMember E30058-000 2016-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:CapitalStockMember E30058-000 2016-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:CapitalSurplusMember E30058-000 2016-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:LegalCapitalSurplusMember E30058-000 2016-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:RetainedEarningsMember E30058-000 2016-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:RetainedEarningsBroughtForwardMember E30058-000 2016-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:ValuationAndTranslationAdjustmentsMember E30058-000 2016-12-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember jppfs_cor:NonConsolidatedMember E30058-000 2016-01-01 2016-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:ShareholdersEquityMember E30058-000 2016-01-01 2016-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:CapitalStockMember E30058-000 2016-01-01 2016-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:CapitalSurplusMember E30058-000 2016-01-01 2016-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:LegalCapitalSurplusMember E30058-000 2016-01-01 2016-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:RetainedEarningsMember E30058-000 2016-01-01 2016-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:RetainedEarningsBroughtForwardMember E30058-000 2016-01-01 2016-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:ValuationAndTranslationAdjustmentsMember E30058-000 2016-01-01 2016-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember E30058-000 2016-01-01 2016-12-31 jppfs_cor:NonConsolidatedMember jpcrp_cor:ReconcilingItemsMember E30058-000 2016-01-01 2016-12-31 jppfs_cor:NonConsolidatedMember jpcrp_cor:ReportableSegmentsMember E30058-000 2016-12-31 jppfs_cor:NonConsolidatedMember E30058-000 2016-01-01 2016-12-31 jppfs_cor:NonConsolidatedMember E30058-000 2015-12-31 jppfs_cor:NonConsolidatedMember E30058-000 2015-01-01 2015-12-31 jppfs_cor:NonConsolidatedMember jpcrp_cor:ReconcilingItemsMember E30058-000 2015-01-01 2015-12-31 jppfs_cor:NonConsolidatedMember jpcrp_cor:ReportableSegmentsMember E30058-000 2016-01-01 2016-12-31 jppfs_cor:NonConsolidatedMember jpcrp030000-asr_E30058-000:DiagnosticDivisionReportableSegmentsMember E30058-000 2015-01-01 2015-12-31 jppfs_cor:NonConsolidatedMember jpcrp030000-asr_E30058-000:DiagnosticDivisionReportableSegmentsMember E30058-000 2016-01-01 2016-12-31 jppfs_cor:NonConsolidatedMember jpcrp030000-asr_E30058-000:PharmaceuticalDivisionReportableSegmentsMember E30058-000 2015-01-01 2015-12-31 jppfs_cor:NonConsolidatedMember jpcrp030000-asr_E30058-000:PharmaceuticalDivisionReportableSegmentsMember E30058-000 2017-03-31 E30058-000 2016-12-31 E30058-000 2016-01-01 2016-12-31 E30058-000 2016-12-31 jpcrp_cor:No10MajorShareholdersMember E30058-000 2016-12-31 jpcrp_cor:No9MajorShareholdersMember E30058-000 2016-12-31 jpcrp_cor:No8MajorShareholdersMember E30058-000 2016-12-31 jpcrp_cor:No7MajorShareholdersMember E30058-000 2016-12-31 jpcrp_cor:No6MajorShareholdersMember E30058-000 2016-12-31 jpcrp_cor:No5MajorShareholdersMember E30058-000 2016-12-31 jpcrp_cor:No4MajorShareholdersMember E30058-000 2016-12-31 jpcrp_cor:No3MajorShareholdersMember E30058-000 2016-12-31 jpcrp_cor:No2MajorShareholdersMember E30058-000 2016-12-31 jpcrp_cor:No1MajorShareholdersMember E30058-000 2015-01-01 2015-12-31 jppfs_cor:SubscriptionRightsToSharesMember jppfs_cor:NonConsolidatedMember E30058-000 2014-12-31 jppfs_cor:SubscriptionRightsToSharesMember jppfs_cor:NonConsolidatedMember E30058-000 2016-12-31 jppfs_cor:SubscriptionRightsToSharesMember jppfs_cor:NonConsolidatedMember E30058-000 2016-01-01 2016-12-31 jppfs_cor:SubscriptionRightsToSharesMember jppfs_cor:NonConsolidatedMember E30058-000 2015-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:SubscriptionRightsToSharesMember E30058-000 2016-01-01 2016-12-31 jppfs_cor:NonConsolidatedMember jpcrp030000-asr_E30058-000:SumMember E30058-000 2016-01-01 2016-12-31 jppfs_cor:NonConsolidatedMember jpcrp030000-asr_E30058-000:OtherDivisionMember E30058-000 2016-01-01 2016-12-31 jppfs_cor:NonConsolidatedMember jpcrp030000-asr_E30058-000:DiagnosticDivisionMember E30058-000 2016-01-01 2016-12-31 jppfs_cor:NonConsolidatedMember jpcrp030000-asr_E30058-000:PharmaceuticalDivisionMember xbrli:pure iso4217:JPY iso4217:JPY xbrli:shares xbrli:shares